Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP331688.RAp1R7oHzo6GSRojU1bqBOMDCS5eBUlSAuMGHazQyt3FY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP331688.RAp1R7oHzo6GSRojU1bqBOMDCS5eBUlSAuMGHazQyt3FY130_assertion type Assertion NP331688.RAp1R7oHzo6GSRojU1bqBOMDCS5eBUlSAuMGHazQyt3FY130_head.
- NP331688.RAp1R7oHzo6GSRojU1bqBOMDCS5eBUlSAuMGHazQyt3FY130_assertion description "[G-CSF has also been applied in priming strategies designed to enhance the sensitivity of leukemia stem cells to cytotoxic agents, in protocols aimed to induce their differentiation and accompanying growth arrest and cell death, and in severe aplastic anemia and myelodysplastic syndrome (MDS) to alleviate anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331688.RAp1R7oHzo6GSRojU1bqBOMDCS5eBUlSAuMGHazQyt3FY130_provenance.
- NP331688.RAp1R7oHzo6GSRojU1bqBOMDCS5eBUlSAuMGHazQyt3FY130_assertion evidence source_evidence_literature NP331688.RAp1R7oHzo6GSRojU1bqBOMDCS5eBUlSAuMGHazQyt3FY130_provenance.
- NP331688.RAp1R7oHzo6GSRojU1bqBOMDCS5eBUlSAuMGHazQyt3FY130_assertion SIO_000772 20237318 NP331688.RAp1R7oHzo6GSRojU1bqBOMDCS5eBUlSAuMGHazQyt3FY130_provenance.
- NP331688.RAp1R7oHzo6GSRojU1bqBOMDCS5eBUlSAuMGHazQyt3FY130_assertion wasDerivedFrom befree-20150227 NP331688.RAp1R7oHzo6GSRojU1bqBOMDCS5eBUlSAuMGHazQyt3FY130_provenance.
- NP331688.RAp1R7oHzo6GSRojU1bqBOMDCS5eBUlSAuMGHazQyt3FY130_assertion wasGeneratedBy ECO_0000203 NP331688.RAp1R7oHzo6GSRojU1bqBOMDCS5eBUlSAuMGHazQyt3FY130_provenance.